Giam Pharma Internationl
Biotechnology Research • 
Monthey, Valais, Switzerland • 1-10 Employees
Company overview
| Headquarters | Monthey, Valais, Switzerland |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Giam Pharma Internationl
Giacomo Drago
Principal Chief Executive Officer
Giam Pharma Internationl Email Formats
Giam Pharma Internationl uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@giampharma.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@giampharma.com | 100% |
About Giam Pharma Internationl
Giam Pharma International Sàrl is a Swiss-based biotech company committed to pioneering innovation in oncology. Building on our deep experience in the therapeutic use of natural extracts, we have transitioned into advanced oncology drug development with a strong focus on safety, toxicity management, and patient quality of life. Our lead asset, Fraisinib, is a first-in-class small molecule targeting GARS1, a metabolic enzyme overexpressed in aggressive tumors such as NSCLC and PDAC. Preclinical studies show potent anti-tumor activity combined with low systemic toxicity. We are currently preparing for GLP-compliant studies and early clinical phases, and we welcome collaboration with partners who share our vision for breakthrough cancer therapies.
Giam Pharma Internationl revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Giam Pharma Internationl has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Giam Pharma Internationl has never raised funding before.
United Kingdom
Netherlands
United States
NorwayFrequently asked questions
4.8
40,000 users
